The HBA1C Analyzers Market is expected to be worth US$ 2 Billion at a CAGR of 5% between 2029. Healthcare is going the “digital” way. In other words, artificial intelligence (AI)-enabled medical devices and telemedicine are the concrete instances of the proliferation of the digital wave in the healthcare industry. This factor would be the one traversing the healthcare vertical in the forecast period.
The increasing prevalence of diabetes remains a key factor fuelling HBA1C sales globally. Increasing geriatric population and the different advantages of HBA1C analyzers over fasting plasma glucose measurements, are also expected to increase the growth of the HBA1C analyzers market. Global sales are likely to reach approximately US$ 2 Bn by the end of 2029, according to a new study by Persistence Market Research (PMR).
Apart from factors driving the growth of the HBA1C analyzers market, there are few factors that are likely to restrain the growth of the HBA1C analyzer market. The poor availability of HBA1C analyzers and lack of awareness regarding HBA1C analyzers in some of the developing regions is expected to hinder the growth of HBA1C analyzers market.
The use of advanced equipment and steerable medical devices continues to gain ground in the healthcare industry. With a long-term focus on early diagnosis and preventive healthcare, new devices are seeing the light of the day, whereas legacy equipment is witnessing a massive upgrade.
Strategizing The Moves For The Next Decade? See Through Sample Of HBA1C Analyzers Market Report! https://www.persistencemarketresearch.co/samples/29293
Company Profiles:
- Abbott
- ApexBio
- ARKRAY, Inc.
- Bio-Rad Laboratories, Inc.
- Convergent Technologies GmbH & Co. KG
- EKF Diagnostics
- Erba Mannheim
- Hoffmann-La Roche Ltd
- HemoCue AB
- i-SENS, Inc.
- labONE, Inc.
- LITE-ON TECHNOLOGY CORPORATION
- Meril Life Sciences Pvt. Ltd.
- OSANG Healthcare
- TaiDoc Technology Corporation
- Tosoh Corporation
- Trinity Biotech
- Zivak Technologies USA
Moreover, the presence of different variants, such as genetic variants, Elevated Fetal Hemoglobin (HbF), and chemically modified derivatives of hemoglobin, can affect the accuracy of HBA1C analyzers.
Increasing per capita healthcare expenditure is one of the main macroeconomic factors that enable people to opt for the appropriate method for the diagnosis of diseases. Changes in the structure of the economy and the availability of technologically advanced HBA1C analyzers are also among factors significantly contributing to the growth of the HBA1C analyzers market.
However, various other dynamics, such as favorable government regulations & reimbursement, increasing healthcare awareness, increasing adoption of HBA1C analyzers, etc., are expected to fuel the growth of the HaA1c analyzers market.
Starting With The New Decade On A Diligent Note In The HBA1C Analyzers Market? https://www.persistencemarketresearch.co/methodology/29293
Several key manufacturers are focusing on mergers and acquisitions. For example, in September 2017, Abbott completed the acquisition of Alere, Inc. In July 2017, Abbott and Bigfoot Biomedical signed an agreement to commercialize diabetes management systems. Moreover, key players operating in the HBA1C market are involved in new product development.
Based on product type, the global HBA1C analyzers market has been segmented into equipment and reagents & consumables. In terms of revenue, the reagents & consumables segment in the global HBA1C analyzers market is expected to hold a significant share over the forecast period.
Based on technology, the global HBA1C analyzers market has been segmented into ion exchange chromatography, high-performance liquid chromatography, high-performance liquid chromatography, and boronate affinity technology. The high-performance liquid chromatography segment is expected to hold a prominent share in the global HBA1C analyzers market.
Based on the modality, the global HBA1C analyzers market has been segmented into portable HBA1C analyzers and benchtop HBA1C analyzers. The benchtop HBA1C analyzers segment is expected to hold a significant share of the global HBA1C analyzers market.
How About Obtaining Insights About The Region To Enter Concerning The HBA1C Analyzers Market? Press The “Purchase Now” Button To Have Our HBA1C Analyzers Market Report! https://www.persistencemarketresearch.com/checkout/29293
Based on end users, the global HBA1C analyzers market has been segmented into hospitals, diagnostic centers, and academic & research institutes. The diagnostic centers segment is expected to account for a major share of the global HBA1C analyzers market.
Geographically, the global HBA1C analyzers market is segmented into Latin America, North America, East Asia, Europe, South Asia, Middle East & Africa, and Oceania. North America followed by Europe is expected to hold a significant revenue share in the global HBA1C analyzers market.
Companies operating in the global HBA1C analyzers market are focusing or merging with other companies to expand the HBA1C analyzers market. Key players of the HBA1C analyzers market are also focusing on new product development and approval.
Access Related Reports-
Patient Positioning Accessories Market @ https://www.prnewswire.com/news-releases/patient-positioning-accessories-market-is-expected-to-exhibit-a-cagr-of-more-than-3-over-the-forecast-period-20212031—persistence-market-research-301268749.html
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com